- Home
- LXRX vs BNY Comparison
LXRX vs BNY Comparison
Compare LXRX & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- BNY
- Stock Information
- Founded
- LXRX 1995
- BNY 2001
- Country
- LXRX United States
- BNY United States
- Employees
- LXRX N/A
- BNY N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- BNY Trusts Except Educational Religious and Charitable
- Sector
- LXRX Health Care
- BNY Finance
- Exchange
- LXRX Nasdaq
- BNY Nasdaq
- Market Cap
- LXRX 273.9M
- BNY 246.8M
- IPO Year
- LXRX 2000
- BNY N/A
- Fundamental
- Price
- LXRX $0.69
- BNY $10.30
- Analyst Decision
- LXRX Buy
- BNY
- Analyst Count
- LXRX 2
- BNY 0
- Target Price
- LXRX $6.00
- BNY N/A
- AVG Volume (30 Days)
- LXRX 5.0M
- BNY 52.7K
- Earning Date
- LXRX 03-10-2025
- BNY 01-01-0001
- Dividend Yield
- LXRX N/A
- BNY 3.93%
- EPS Growth
- LXRX N/A
- BNY N/A
- EPS
- LXRX N/A
- BNY N/A
- Revenue
- LXRX $5,229,000.00
- BNY N/A
- Revenue This Year
- LXRX $842.94
- BNY N/A
- Revenue Next Year
- LXRX $19.76
- BNY N/A
- P/E Ratio
- LXRX N/A
- BNY N/A
- Revenue Growth
- LXRX 886.60
- BNY N/A
- 52 Week Low
- LXRX $0.62
- BNY $8.60
- 52 Week High
- LXRX $3.73
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- LXRX 40.93
- BNY 46.21
- Support Level
- LXRX $0.70
- BNY $10.18
- Resistance Level
- LXRX $0.75
- BNY $10.28
- Average True Range (ATR)
- LXRX 0.08
- BNY 0.09
- MACD
- LXRX -0.00
- BNY 0.01
- Stochastic Oscillator
- LXRX 7.14
- BNY 61.85
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.